Public recall detail

PMS-CINACALCET: Affected lots may exceed the established acceptable intake limit for N-nitroso-cinacalcet.

2024-12-30

medium
Recall Safety notice
Quick summary

Quick summary: PMS-CINACALCET: Affected lots may exceed the established acceptable intake limit for N-nitroso-cinacalcet.. Date: 2024-12-30.

Recommended action

Recommended action: compare your product with the official notice and follow the instructions published by the official source.

Recall details

Quick summary: PMS-CINACALCET: Affected lots may exceed the established acceptable intake limit for N-nitroso-cinacalcet.. Date: 2024-12-30.

Official details

Affected product details

Structured information extracted from the official recall notice. Confirm the identifiers and instructions in the original notice.

BrandPharmascience Inc., PHARMASCIENCE INC
ProductPMS-CINACALCET Tablets (30MG, 60 MG, 90 MG)
IssueHealth products - Product safety
Recall classType I
IdentificationRA-76775

Affected products

BrandPHARMASCIENCE INC
ProductPMS-CINACALCET
DIN / NPN / authorizationDIN 02517604
Dosage formTablet
StrengthCINACALCET (CINACALCET HYDROCHLORIDE) 30 MG
LotT2304707
BrandPHARMASCIENCE INC
ProductPMS-CINACALCET
DIN / NPN / authorizationDIN 02517612
Dosage formTablet
StrengthCINACALCET (CINACALCET HYDROCHLORIDE) 60 MG
LotT2304708
BrandPHARMASCIENCE INC
ProductPMS-CINACALCET
DIN / NPN / authorizationDIN 02517620
Dosage formTablet
StrengthCINACALCET (CINACALCET HYDROCHLORIDE) 90 MG
LotT2304718

Issue

The affected lots may exceed the established acceptable intake limit for N-nitroso-cinacalcet.

What you should do

  • Verify if your product is affected.
  • Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns.
  • Contact the recalling firm if you have any questions about the recall.
  • Report any health product related side effects to Health Canada.
  • Report any other health product safety complaints to Health Canada.
Additional official information
AudienceGeneral public Healthcare Industry
CategoryHealth products - Drugs
CompaniesPHARMASCIENCE INC 100 6111 Royalmount Ave Montreal QUÉBEC CANADA H4P 2T4
DistributionNational
Published byHealth Canada
Recall classType I
Alert / recall typeHealth product recall
Identification numberRA-76775
Background{}
CompaniesPHARMASCIENCE INC 100 6111 Royalmount Ave Montreal QUÉBEC CANADA H4P 2T4
AudiencesGeneral public Healthcare Industry
Source updated2024-12-30

Contains information licensed under the Open Government Licence – Canada. SafetyPulse is independent of the Government of Canada.

Official source Monitor products Back to recalls

Starting...

Related recalls

Similar recalls and safety notices.

Loading related recalls...